CHO Pharma, Inc. (TPEX: 6586)

CHO Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,948	14,830	25,204	15,354	4,575	4,421
Market Cap Growth	-8.68%	-41.16%	64.15%	235.65%	3.48%	-20.37%
Enterprise Value	10,494	13,944	24,033	13,969	2,948	2,468
Last Close Price	60.50	69.30	137.00	83.50	24.90	24.10
PE Ratio	-	-43.31	-74.46	-74.55	-15.37	-12.30
PS Ratio	11536.99	-	420067.12	4300.98	33148.76	14883.86
PB Ratio	4.50	4.98	17.64	8.80	2.33	1.95
P/FCF Ratio	-57.80	-50.59	-97.35	-78.30	-17.08	-15.89
P/OCF Ratio	-58.94	-50.94	-101.02	-79.36	-18.39	-16.57
EV/Sales Ratio	10965.27	-	400545.33	3912.98	21363.14	8308.71
EV/EBITDA Ratio	-54.62	-55.71	-74.02	-75.56	-10.45	-7.26
EV/EBIT Ratio	-51.18	-51.84	-68.49	-66.37	-9.52	-6.68
EV/FCF Ratio	-41.93	-47.57	-92.83	-71.23	-11.01	-8.87
Debt / Equity Ratio	0.01	-	0.01	0.01	0.02	0.02
Debt / FCF Ratio	-0.14	-	-0.05	-0.13	-0.14	-0.15
Asset Turnover	0.00	-	0.00	0.00	0.00	0.00
Quick Ratio	23.03	24.57	6.19	9.89	10.22	13.59
Current Ratio	23.43	24.93	6.39	10.06	10.37	13.72
Return on Equity (ROE)	-12.29%	-13.90%	-21.33%	-11.11%	-14.05%	-14.71%
Return on Assets (ROA)	-6.52%	-7.17%	-12.55%	-6.52%	-8.47%	-9.05%
Return on Capital (ROIC)	-6.91%	-7.62%	-13.66%	-6.98%	-8.99%	-9.39%
Earnings Yield	-2.05%	-2.06%	-1.34%	-1.34%	-6.49%	-8.11%
FCF Yield	-1.93%	-1.98%	-1.03%	-1.28%	-5.86%	-6.29%
Buyback Yield / Dilution	-12.15%	-4.00%	-0.04%	-0.12%	-0.36%	-0.84%
Total Shareholder Return	-12.15%	-4.00%	-0.04%	-0.12%	-0.36%	-0.84%

Source: S&P Capital IQ. Standard template. Financial Sources.